Trade-off between bleeding and thrombotic risk in patients with academic research consortium for high bleeding risk

Hironori Hara; Masafumi Ono; Hideyuki Kawashima; Yoshinobu Onuma; Patrick W. Serruys

doi:https://doi.org/10.1001/jamacardio.2021.1558

Trade-off between bleeding and thrombotic risk in patients with academic research consortium for high bleeding risk

Hironori Hara, Masafumi Ono, Hideyuki Kawashima, Yoshinobu Onuma, Patrick W. Serruys

Research output: Contribution to journal › Comment/Letter to the editor › Academic

2 Citations (Scopus)

Original language	English
Article number	hld210003
Pages (from-to)	1092-1094
Number of pages	3
Journal	JAMA Cardiology
Volume	6
Issue number	9
Early online date	2021
DOIs	https://doi.org/10.1001/jamacardio.2021.1558
Publication status	Published - Sept 2021

Access to Document

https://doi.org/10.1001/jamacardio.2021.1558

Cite this

@article{b76858029ab3414e855664993d0e26b5,

title = "Trade-off between bleeding and thrombotic risk in patients with academic research consortium for high bleeding risk",

author = "Hironori Hara and Masafumi Ono and Hideyuki Kawashima and Yoshinobu Onuma and Serruys, {Patrick W.}",

note = "Funding Information: Funding/Support: GLOBAL LEADERS study was sponsored by the European Clinical Research Institute, which received funding from Biosensors International, AstraZeneca, and the Medicines Company. Funding Information: Conflict of Interest Disclosures: Dr Hara reported grants from the Japanese Circulation Society and Fukuda Foundation for Medical Technology outside the submitted work. Dr Serruys reported personal fees from Biosensors, Micel Technologies, Sinomedical Sciences Technology, Philips/Volcano, Xeltis, and HeartFlow outside the submitted work. No other disclosures were reported. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = sep,

doi = "https://doi.org/10.1001/jamacardio.2021.1558",

language = "English",

volume = "6",

pages = "1092--1094",

journal = "JAMA Cardiology",

issn = "2380-6583",

publisher = "American Medical Association",

number = "9",

}

TY - JOUR

T1 - Trade-off between bleeding and thrombotic risk in patients with academic research consortium for high bleeding risk

AU - Hara, Hironori

AU - Ono, Masafumi

AU - Kawashima, Hideyuki

AU - Onuma, Yoshinobu

AU - Serruys, Patrick W.

N1 - Funding Information: Funding/Support: GLOBAL LEADERS study was sponsored by the European Clinical Research Institute, which received funding from Biosensors International, AstraZeneca, and the Medicines Company. Funding Information: Conflict of Interest Disclosures: Dr Hara reported grants from the Japanese Circulation Society and Fukuda Foundation for Medical Technology outside the submitted work. Dr Serruys reported personal fees from Biosensors, Micel Technologies, Sinomedical Sciences Technology, Philips/Volcano, Xeltis, and HeartFlow outside the submitted work. No other disclosures were reported. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/9

Y1 - 2021/9

UR - http://www.scopus.com/inward/record.url?scp=85107834489&partnerID=8YFLogxK

U2 - https://doi.org/10.1001/jamacardio.2021.1558

DO - https://doi.org/10.1001/jamacardio.2021.1558

M3 - Comment/Letter to the editor

C2 - 34076662

SN - 2380-6583

VL - 6

SP - 1092

EP - 1094

JO - JAMA Cardiology

JF - JAMA Cardiology

IS - 9

M1 - hld210003

ER -

Trade-off between bleeding and thrombotic risk in patients with academic research consortium for high bleeding risk

Access to Document

Other files and links

Cite this